Dales Gardner Cameron 4

4 · Enovix Corp · Filed Jul 16, 2021

Form 4

Period: 2021-07-14

Chief Commercial Officer

Transactions

Award
Stock Option (Right to Buy)
2021-07-14+110,176→ 110,176 total
Exercise: $9.26Exp: 2031-04-19→ Common Stock (110,176 underlying)
Award
Common Stock
2021-07-14+988,603→ 988,603 total
Award
Stock Option (Right to Buy)
2021-07-14+13,845→ 13,845 total
Exercise: $0.05Exp: 2027-12-13→ Common Stock (13,845 underlying)

Footnotes (5)

[F1]Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation.
[F2]The shares subject to the option vest in 48 equal monthly installments beginning on the vesting commencement date, September 1, 2017, subject to Reporting Person's continuous service through each such vesting date.
[F3]Received in exchange for a stock option to purchase 75,000 shares of Legacy Enovix Common Stock.
[F4]The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date.
[F5]Received in exchange for a stock option to purchase 596,800 shares of Legacy Enovix Common Stock.

Documents

2 files